Lv7
4990 积分 2021-03-01 加入
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study
19天前
已完结
Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study
1个月前
已完结
Prevalence of Chronic Kidney Disease in China Results From the Sixth China Chronic Disease and Risk Factor Surveillance
1个月前
已完结
Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry
3个月前
已完结
Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial
4个月前
已完结
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial
4个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
4个月前
已完结
Presence of hepatitis B virus markers in umbilical cord blood: Exposure to or infection with the virus?
4个月前
已完结
Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss
4个月前
已完结
HOW DO PATIENTS EXPERIENCE A KIDNEY BIOPSY?
4个月前
已完结
皖公网安备34019202002308
